Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population.
Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, Gomes NMF, de Oliveira EMG, Rotman V, de Oliveira MB, da Cunha SMCF, Mazo DFC, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, Pace FHL, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Cançado GGL, et al. Among authors: pessoa mg. Ann Hepatol. 2022 Jan-Feb;27(1):100546. doi: 10.1016/j.aohep.2021.100546. Epub 2021 Sep 30. Ann Hepatol. 2022. PMID: 34600142 Free article.
[National survey about management and treatment options of hepatitis C recurrence after liver transplantation].
Bittencourt PL, Silva Rde C, Pessoa MG, Marroni CA; Colaboradores do Inquérito Nacional de Avaliação de Impacto de Recurrência da Hepatite C no Pós-Operatório do Transplante de Fígado. Bittencourt PL, et al. Among authors: pessoa mg. Arq Gastroenterol. 2007 Jan-Mar;44(1):78-84. doi: 10.1590/s0004-28032007000100017. Arq Gastroenterol. 2007. PMID: 17639189 Free article. Portuguese.
Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial.
Pessôa MG, Cheinquer H, Almeida PR, Silva GF, Lima MP, Paraná R, Lacerda MA, Parise ER, Pernambuco JR, Pedrosa SS, Teixeira R, Sette H Jr, Tatsch F. Pessôa MG, et al. Ann Hepatol. 2012 Jan-Feb;11(1):52-61. Ann Hepatol. 2012. PMID: 22166561 Free article. Clinical Trial.
Disease burden of chronic hepatitis C in Brazil.
Ferreira PR, Brandão-Mello CE, Estes C, Gonçales Júnior FL, Coelho HS, Razavi H, Cheinquer H, Wolff FH, Ferraz ML, Pessoa MG, Mendes-Correa MC. Ferreira PR, et al. Among authors: pessoa mg. Braz J Infect Dis. 2015 Jul-Aug;19(4):363-8. doi: 10.1016/j.bjid.2015.04.004. Epub 2015 Jun 4. Braz J Infect Dis. 2015. PMID: 26051505 Free PMC article.
Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study.
Callefi LA, Villela-Nogueira CA, de Barros Tenore S, Carnaúba-Júnior D, Coelho HSM, Pinto PTA, Nabuco LC, Pessoa MG, Ferraz MLCG, Ferreira PRA, de Lourdes Candolo Martinelli A, Chachá SGF, de Souza Paiva Ferreira A, de Macedo Bisio AP, Brandão-Mello CE, Álvares-Da-Silva MR, Reuter T, Ivantes CAP, de Mello Perez R, Mendes-Correa MCJ. Callefi LA, et al. Among authors: pessoa mg. Clinics (Sao Paulo). 2017 Jun;72(6):378-385. doi: 10.6061/clinics/2017(06)08. Clinics (Sao Paulo). 2017. PMID: 28658438 Free PMC article. Clinical Trial.
Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus.
Grando AV, Ferreira PRA, Pessôa MG, Mazo DFC, Brandão-Mello CE, Reuter T, Martinelli ALC, Gonzalez MP, Nastri ACS, Campos AF, Lopes MIBF, Brito JDU, Mendes-Corrêa MC. Grando AV, et al. Among authors: pessoa mg. Rev Inst Med Trop Sao Paulo. 2017 Nov 6;59:e67. doi: 10.1590/S1678-9946201759067. Rev Inst Med Trop Sao Paulo. 2017. PMID: 29116287 Free PMC article.
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.
Pessoa MG, Ramalho-Madruga JV, Alves K, Nunes EP, Cheinquer H, Brandão-Mello CE, Mendes-Correa MC, Ferraz ML, Ferreira PRA, Álvares-da-Silva MR, Coelho HS, Affonso-de-Araújo ES, Furtado J, Parana R, Silva G, Lari SA, Liu L, Tripathi R, Pilot-Matias T, Cohen DE, Shulman NS, Martinelli A. Pessoa MG, et al. Ann Hepatol. 2018 Oct 16;17(6):959-968. doi: 10.5604/01.3001.0012.7196. Ann Hepatol. 2018. PMID: 30600291 Free article. Clinical Trial.
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil.
Lobato CMO, Codes L, Silva GF, Souza AFM, Coelho HSM, Pedroso MLA, Parise ER, Lima LMSTB, Borba LA, Evangelista AS, Rezende REF, Cheinquer H, Kuniyoshi ASO, Aires RS, Quintela EHD, Mendes LSC, Nascimento FCV, Medeiros Filho JEM, Ferraz MLCG, Abdala E, Bittencourt PL; Members of the Brazilian Real-Life Study about HCV treatment; Members of the Brazilian Real-Life Study about HCV treatment. Lobato CMO, et al. Ann Hepatol. 2019 Nov-Dec;18(6):849-854. doi: 10.1016/j.aohep.2019.08.001. Epub 2019 Aug 30. Ann Hepatol. 2019. PMID: 31537509 Free article.
88 results